Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AudibleHealth AI’s flagship product suite uses advanced artificial intelligence to analyze cough sounds recorded via smartphone/web apps to screen for respiratory diseases. In a prospective multi-site trial with over five hundred participants evaluating the COVID‑19 test versus RT-PCR reference standard, the software achieved a Positive Percent Agreement of ~84% and Negative Percent Agreement of ~85%. The company has submitted an Emergency Use Authorization application to the FDA based on these results. The tuberculosis screening solution launched commercially in seven countries in early 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AudibleHealth AI.